Board of Directors
Gordon McCauley (Chair)
President & CEO, Centre for Drug Research and Development
Mark Caulfield
Co-Director of the William Harvey Research Institute & Chief Executive and Chief Scientist for Genomics England
Martha Crago
PhD (Vice-President Research & Innovation, McGill University)
Philippe Gros
Ph.D. (Professor, Department of Biochemistry, McGill University)
Paul D.N. Hebert
OC, FRSC, PhD (Director, Centre for Biodiversity Genomics, University of Guelph)
Roderick R McInnes
CM, MD, PhD, FRSC (Director, Lady Davis Research Institute, Jewish General Hospital)
Michael Salter
MD, PhD, FRSC (Chief of Research, Hospital for Sick Children)
Sharon Wu
Managing Director, Vice-President Research & Innovation Portfolio, University of British Columbia
Scientific Advisory Board
Edward M Rubin (Chair)
MD, PhD (Chief Scientific Officer, Metabiota)
Elaine R Mardis
PhD (Co-Director, Institute for Genomic Medicine, Nationwide Children’s Hospital)
Gabor Marth
DSc (Professor of Human Genetics, University of Utah)
Roderick R McInnes
CM, MD, PhD, FRSC (Director, Lady Davis Research Institute, Jewish General Hospital)
Richard M Myers
PhD (President and Science Director of the HudsonAlpha Institute for Biotechnology)
TBC
Executive Committee
Naveed Aziz
PhD, MBA (CGEn, Chief Administrative & Scientific Officer)
Steve Jones
PhD (CGEn-GSC, University of British Columbia and BC Cancer Agency)
Mark Lathrop
PhD (CGEn-MUGQIC, McGill University)
Stephen Scherer
PhD (CGEn-TCAG, SickKids and University of Toronto)